Here are two I’m looking to add as we head into what could be another frustrating year for stocks.

The announced shakeup is the biggest in the company's 135-year history.

Endo is to pay $63 million to Texas to settle claims made by the state and counties that the company was implicit in fueling the opioid crisis in the state.

Compared to its peers like Johnson and Johnson, and Merck, who are also vaccine manufacturers, Pfizer is a better bet and gives higher expected returns.

Take a look at a few trending biotech stocks and decide if this is something you want to invest in.

Olson claimed that she got cancer because of asbestos exposure from Johnson & Johnson baby powder.

Johnson & Johnson to enroll 60,000 participants in the late-stage trial for its COVID-19 vaccine.